Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May;12(10):811-812.
doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.

Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents

Sameer Ayaz  1 , Francesco Crea  1
Affiliations
Editorial

Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents

Sameer Ayaz et al. Epigenomics. 2020 May.
No abstract available

Keywords: COVID-19; EZH2; SARS-Cov-2; epigenetics; polycomb.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

References

    1. Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Med. Wkly. 150 w20224 (2020). - PubMed
    1. Group CC-19 W. Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ. The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: A modelling study. medRxiv. (2020) (Epub ahead of print). - PMC - PubMed
    1. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N. Engl. J. Med. (2020) (Epub ahead of print). - PubMed
    1. Yang Y, Shen C, Li J. et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. medRxiv. (2020) (Epub ahead of print).
    1. Wang M, Cao R, Zhang L. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30(3), 269–971 (2020). - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources